Zanamivir–Cholesterol Conjugate: A Long-Acting Neuraminidase Inhibitor with Potent Efficacy against Drug-Resistant Influenza Viruses

Cytosolic delivery of proteins by cholesterol tagging

(2020) Wanyi Tai et al.   Science Advances

Prevention and treatment of SHIVAD8 infection in rhesus macaques by a potent d-peptide HIV entry inhibitor

(2020) Yoshiaki Nishimura et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

SIP/CacyBP promotes autophagy by regulating levels of BRUCE/Apollon, which stimulates LC3-I degradation

(2019) Tian-Xia Jiang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Noncovalent tagging of siRNA with steroids for transmembrane delivery

(2018) Wanyi Tai et al.   BIOMATERIALS

Acylguanidine derivatives of zanamivir and oseltamivir: Potential orally available prodrugs against influenza viruses

(2018) Peng-Hao Hsu et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant

(2018) Jian Zhang et al.   JOURNAL OF MEDICINAL CHEMISTRY

Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents

(2018) Frederick G. Hayden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Structure-Based Tetravalent Zanamivir with Potent Inhibitory Activity against Drug-Resistant Influenza Viruses

(2016) Lifeng Fu et al.   JOURNAL OF MEDICINAL CHEMISTRY

Self-organizing behaviour of glycosteroidal bolaphiles: insights into lipidic microsegregation

(2015) R. Xu et al.   ORGANIC & BIOMOLECULAR CHEMISTRY

Analysis of Influenza Virus Receptor Specificity Using Glycan-Functionalized Gold Nanoparticles

(2014) Jinhua Wei et al.   ACS Nano

Development of Novel Potent Orally Bioavailable Oseltamivir Derivatives Active against Resistant Influenza A

(2014) Dennis Schade et al.   JOURNAL OF MEDICINAL CHEMISTRY

Oseltamivir Analogues Bearing N-Substituted Guanidines as Potent Neuraminidase Inhibitors

(2014) Caitlin A. Mooney et al.   JOURNAL OF MEDICINAL CHEMISTRY

Discovery of N-Substituted Oseltamivir Derivatives as Potent and Selective Inhibitors of H5N1 Influenza Neuraminidase

(2014) Yuanchao Xie et al.   JOURNAL OF MEDICINAL CHEMISTRY

A Prospective Study of Romanian Agriculture Workers for Zoonotic Influenza Infections

(2014) Alexandru Coman et al.   PLoS One

Favipiravir (T-705), a novel viral RNA polymerase inhibitor

(2013) Yousuke Furuta et al.   ANTIVIRAL RESEARCH

Characteristics of a Widespread Community Cluster of H275Y Oseltamivir-Resistant A(H1N1)pdm09 Influenza in Australia

(2012) A. C. Hurt et al.   JOURNAL OF INFECTIOUS DISEASES

Polymer-attached zanamivir inhibits synergistically both early and late stages of influenza virus infection

(2012) C. M. Lee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A Light-Stimulated Molecular Switch Driven by Radical-Radical Interactions in Water

(2011) Hao Li et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

The synthesis of cholesterol-based cationic lipids with trimethylamine head and the effect of spacer structures on transfection efficiency

(2011) Bieong-Kil Kim et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Postpartum Pharmacokinetics of Peramivir in the Treatment of 2009 H1N1 Influenza

(2011) Patrick G. Clay et al.   OBSTETRICS AND GYNECOLOGY

Detection of E119V and E119I Mutations in Influenza A (H3N2) Viruses Isolated from an Immunocompromised Patient: Challenges in Diagnosis of Oseltamivir Resistance

(2010) M. Okomo-Adhiambo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Pharmacokinetics of Laninamivir, a Novel Long-Acting Neuraminidase Inhibitor, After Single and Multiple Inhaled Doses of Its Prodrug, CS-8958, in Healthy Male Volunteers

(2010) Hitoshi Ishizuka et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Carbocycles Related to Oseltamivir as Influenza Virus Group-1-Specific Neuraminidase Inhibitors. Binding to N1 Enzymes in the Context of Virus-like Particles

(2010) Sankar Mohan et al.   JOURNAL OF MEDICINAL CHEMISTRY

Structures of influenza A proteins and insights into antiviral drug targets

(2010) Kalyan Das et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Novel sialic acid derivatives lock open the 150-loop of an influenza A virus group-1 sialidase

(2010) Santosh Rudrawar et al.   Nature Communications

Global Transmission of Oseltamivir-Resistant Influenza

(2009) Anne Moscona   NEW ENGLAND JOURNAL OF MEDICINE

Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis

(2009) Mariana Baz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency

(2009) P. Ingallinella et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Update on Avian Influenza A (H5N1) Virus Infection in Humans

(2008)   NEW ENGLAND JOURNAL OF MEDICINE